MedTrace Logo

Prospective Assessment of Robotic Sacrocolpopexy: a European Multicentric Cohort (PARSEC)

NCT01598467 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2018-02-22

No results posted yet for this study

Summary

The purpose of this study is to prospectively assess the outcomes of robotic sacrocolpopexy for repair of pelvic organ prolapse in high volume european centers.

Conditions

  • Pelvic Organ Prolapse

Interventions

PROCEDURE

Robotic assisted sacrocolpopexy (RASC)

Robotic assisted sacrocolpopexy (RASC) will be performed with the Da Vinci Surgical robot (Intuitive Surgical). THe mesh used will be a Type I (Amid classification), polypropylene mesh

Sponsors & Collaborators

  • Femke van Zanten

    lead OTHER

Principal Investigators

  • Barry O'Reilly · Cork University Hospital

  • Steven E Schraffordt Koops · Department of Gynecology and Obstetrics, Meander Medical Center, Amersfoort, The Netherlands

  • Lorenzo Dutto · Cork University Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2021-08-31
Completion
2022-08-31

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01598467 on ClinicalTrials.gov